BREKIYA
NDC 64896-509, Dihydroergotamine Mesylate, injection, from Amneal Pharmaceuticals LLC.
- Product NDC
- 64896-509
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215400
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64896-509 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIHYDROERGOTAMINE MESYLATE1 mg/mL
Pharmacologic classes
Ergotamine Derivative [EPC]; Ergotamines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64896-509-02 | 64896050902 | 4 POUCH in 1 CARTON (64896-509-02) / 1 SYRINGE in 1 POUCH / 1 mL in 1 SYRINGE (64896-509-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cdbf5619-767f-4165-aec2-17bdd92d9ca2
Use it
Look up 64896-509 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64896-509 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64896-509. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.